Concert Pharmaceuticals Inc CNCE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 2:22 PM EDT
3.33quote price arrow down-0.12 (-3.48%)
Volume
34,321
52 week range
3.12 - 13.50
Loading...
  • Open3.46
  • Day High3.46
  • Day Low3.32
  • Prev Close3.45
  • 52 Week High13.50
  • 52 Week High Date12/11/20
  • 52 Week Low3.12
  • 52 Week Low Date09/14/21

Key Stats

  • Market Cap107.13M
  • Shares Out32.17M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.48
  • YTD % Change-73.66

KEY STATS

  • Open3.46
  • Day High3.46
  • Day Low3.32
  • Prev Close3.45
  • 52 Week High13.50
  • 52 Week High Date12/11/20
  • 52 Week Low3.12
  • 52 Week Low Date09/14/21
  • Market Cap107.13M
  • Shares Out32.17M
  • 10 Day Average Volume0.06M
  • Dividend-
  • Dividend Yield-
  • Beta0.48
  • YTD % Change-73.66

RATIOS/PROFITABILITY

  • EPS (TTM)-1.79
  • P/E (TTM)-1.86
  • Fwd P/E (NTM)-0.94
  • EBITDA (MRQ)-57.04M
  • ROE (MRQ)-43.88%
  • Revenue (MRQ)33.53M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-174.60%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Concert Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Concert Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of small molecule drugs. The Company operates through the development of pharmaceutical products on its own behalf or in collaboration with others. The Company's deuterated chemical entity platform (DCE Platform), has potential across various therapeutic areas. Its product candidates include AVP-786, CTP-656, CTP-730, CTP-543 and JZP-386. The...
Richard Aldrich
Non-Executive Chairman
Roger Tung Ph.D.
President
Nancy Stuart
Chief Operating Officer
Marc Becker CPA
Chief Financial Officer
Address
65 Hayden Ave Ste 3000N
Lexington, MA
02421-7994
United States

Top Peers

SYMBOLLASTCHG%CHG
SBBP
Strongbridge Biopharma plc
2.08-0.03-1.52%
XERS
Xeris Pharmaceuticals Inc
2.50-0.05-1.96%
CDTX
Cidara Therapeutics Inc
2.10+0.01+0.48%
ENVB
Enveric Biosciences Inc
2.77+0.12+4.53%
ORGS
Orgenesis Inc
4.93-0.03-0.60%